#SFHS2612549AIbuprofen EG Labo 200 mg added to France's approved medicines list for public services
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This order adds Ibuprofen EG Labo 200 mg film-coated tablets to the list of medicines approved for use by public healthcare facilities and public services in France. Health insurance coverage is limited to short-term treatment of fever and pain, including headaches, flu-like symptoms, dental pain, muscle aches, and menstrual pain, for adults and children over 20 kg, roughly age 6 and above.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Adds Ibuprofen EG Labo 200 mg film-coated tablets to the approved medicines list for public facilities and services
- Limits reimbursed use to short-term treatment of fever and common pain symptoms
- Defines the eligible patient group as adults and children over 20 kg, roughly age 6 and above
Obligations
What this law requires
Public healthcare facilities and other public services may use IBUPROFENE EG LABO 200 mg film-coated tablets, CIP 34009 303 246 4 6, as the product is added to the approved list of pharmaceutical specialties for collective/public-service use.
Health insurance reimbursement for IBUPROFENE EG LABO 200 mg film-coated tablets is limited to short-term treatment of fever and/or pain, including headaches, flu-like symptoms, dental pain, muscle aches, and menstrual pain, in adults and children over 20 kg, approximately 6 years and older.